Inflammation-mediated Coronary Plaque Vulnerability, Myocardial Viability and Ventricular Remodeling (VIABILITY)
Impact of Inflammation-mediated Response on Pan-coronary Plaque Vulnerability, Myocardial Viability and Ventricular Remodeling in the Post-infarction Period - the VIABILITY Study
Sponsor: Cardio Med Medical Center
A observational or N/A phase clinical study on Acute Myocardial Infarction and Heart Failure, this trial is completed. The trial is conducted by Cardio Med Medical Center and has accumulated 9 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Apr 2022 — Sep 2022 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2019 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Mar 2019 — Aug 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cardio Med Medical Center
- George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures
- Tîrgu Mureș Emergency Clinical County Hospital, Romania
For direct contact, visit the study record on ClinicalTrials.gov .